Drugs / Sunobinop
Sunobinop
also known as
V117957 · IMB-115 · IMB-115 tosylate · RSC-117957 · RSC-117957 TOSYLATE · SUNOBINOP TOSYLATE · V-117957 TOSYLATE
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT06024642 | Jun 2022 → May 2024 | overactive bladder | Imbrium Therapeutics | Completed | No outcome recorded |
| Phase 1 | NCT06285214 | May 2022 → Jan 2025 | interstitial cystitis | Imbrium Therapeutics | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT06545929 | Jan → Jul 2025 | alcohol-related disorders | Knoa Pharma LLC | Completed | No outcome recorded |
| Phase 2 | NCT06545916 | Oct 2024 → May 2026 | alcohol-related disorders | Knoa Pharma LLC | Completed | No outcome recorded |
| Phase 2 | NCT04035200 | Sep 2019 → Nov 2020 | insomnia | Imbrium Therapeutics | Completed | No outcome recorded |
| Phase 2 | NCT01900795 | Jul → Nov 2013 | — | Purdue Pharma LP | Terminated | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sunobinop | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06545929 ↗ |
| Known as | IMB-115 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095040 ↗ |
| Known as | IMB-115 tosylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095040 ↗ |
| Known as | RSC-117957 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095040 ↗ |
| Known as | RSC-117957 TOSYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095040 ↗ |
| Known as | SUNOBINOP TOSYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095040 ↗ |
| Known as | V-117957 TOSYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095040 ↗ |
| Known as | V117957 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06285214 ↗ |
| Modality | Small molecule | — CHEMBL5095040 ↗ |
| Route | Oral | “taken orally after surgery.” NCT01900795 ↗ |